Cardiac Remodelling in Pressure Overload Hypertrophy

  • Ute Seeland
  • Michael Böhm
Part of the Proteases in Biology and Disease book series (PBAD, volume 1)


Ventricular remodelling is the basis of differences in cardiac structure as hypertrophy due to pressure overload or ventricular dilation leading to heart failure. The heart structure is essentially influenced by the extracellular matrix (ECM). Only in this scaffold cardiac myocytes and vascular cells can do their function and a normal myocardial contractility is possible. The structure of the cardiac extracellular matrix depends on cardiac fibroblast collagen synthesis, on the activity of fibrillar collagen degrading proteolytic enzymes and their endogenous tissue inhibitors. The main component of the ECM are the fibrillar collagens. Collagen type I and type III are the major types present in myocardium in both normal and diseased myocardial tissue. Other collagens like type IV and type VII are important for basement membrane stability. Collagen biosynthesis is regulated at different levels of transcription and translation.


Myocardial Fibrosis Cardiac Remodelling Pressure Overload Cardiac Fibroblast Myocardial Hypertrophy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Adams, J.W., Sakata, Y., Davis, M.G., Sah, V.P., Wang, Y., Liggett, S.B., Chien, K.R., Brown, J.H., Dorn, G.W. 2nd., 1998, Enhanced Gaq signaling: a common pathway mediates cardiac hypertrophy and apoptotic heart failure. Proc. Natl. Acad. Sci. U.S.A. 95: 10140–10145.PubMedCentralPubMedCrossRefGoogle Scholar
  2. Baudin, B., 2002, Angiotensin II receptor polymorphisms in hypertension. Pharmacogenomic considerations. Pharmacogenomics. 3: 65–73.PubMedCrossRefGoogle Scholar
  3. Blobe, G.C., Schiemann, W.P., Lodish, H.F., 2000, Role of transforming growth factor beta in human disease. N. Engl. J. Med. 342: 1350–1358.PubMedCrossRefGoogle Scholar
  4. Böhm, M., Flesch, M., Schnabel, P., 1997, Beta-adrenergic signal transduction in the failing and hypertrophied myocardium. J. Mol. Med. 75: 842–848.PubMedCrossRefGoogle Scholar
  5. Border, W.A., Noble, N.A., 1994, Transforming growth factor beta in tissue fibrosis. N. Engl. J. Med. 331: 1286–1292.PubMedCrossRefGoogle Scholar
  6. Brenner, D.A., Rippe, R.A., Rhodes, K., Trotter, J.F., Breindl, M, 1994, Fibrogenesis and type I collagen gene regulation. J. Lab. Clin. Med. 124: 755–760.PubMedGoogle Scholar
  7. Brilla, C.G., Zhou, G., Matsubara, L., Weber, K.T., 1994, Collagen metabolism in cultured adult rat cardiac fibroblasts: response to angiotensin II and aldosterone. J. Mol. Cell. Cardiol. 26: 809–820.PubMedCrossRefGoogle Scholar
  8. Butt, R.P., Laurent, G.J., Bishop, J.E., 1995, Collagen production and replication by cardiac fibroblasts is enhanced in response to diverse classes of growth factors. Eur. J. Cell Biol. 68: 330–335.PubMedGoogle Scholar
  9. Catellano, M., Böhm, M., 1997, The cardiac β-adrenoceptor-mediated signaling pathway and its alterations in hypertensive heart disease. Hypertension. 29: 715–722.CrossRefGoogle Scholar
  10. Coker, M.L., Jolly, J.R., Joffs, C., Etoh, T., Holder, J.R., Bond, B.R., Spinale, F.G., 2001, Matrix metalloproteinase expression and activity in isolated myocytes after neurohormonal stimulation. Am. J. Physiol. Heart. Circ. Physiol. 281: H543–551.PubMedGoogle Scholar
  11. Dostal, D.E., 2001, Regulation of cardiac collagen: angiotensin and cross-talk with local growth factors. Hypertension. 37: 841–844.PubMedCrossRefGoogle Scholar
  12. Edwards, D.R., Murphy, G., Reynolds, J.J., Whitham, S.E., Docherty, A.J., Angel, P., Heath, J.K., 1987,Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor. EMBO J. 6: 1899–1904.PubMedCentralPubMedGoogle Scholar
  13. Everett, A.D., Tufro-McReddie, A., Fisher, A., Gomez, R.A., 1994, Angiotensin receptor regulates cardiac hypertrophy and transforming growth factor-beta 1 expression. Hypertension. 23: 587–592.PubMedCrossRefGoogle Scholar
  14. Fujisaki, H., Ito, H., Hirata, Y., Tanaka, M., Hata, M., Lin, M., Adachi, S., Akimoto, H., Marumo, F., Hiroe, M., 1995, Natriuretic peptides inhibit angiotensin II-induced proliferation of rat cardiac fibroblasts by blocking endothelin-1 gene expression. J. Clin. Invest. 96: 1059–1065.PubMedCentralPubMedCrossRefGoogle Scholar
  15. Gonzalez, A., Lopez, B., and Diez, J., 2002, Myocardial fibrosis in arterial hypertension. Eur. Heart J. Suppl. 4: D18–D22.Google Scholar
  16. Guarda, E., Katwa, L.C., Myers, P.R., Tyagi, S.C., Weber, K.T., 1993, Effects of endothelins on collagen turnover in cardiac fibroblasts. Cardiovasc. Res. 27: 2130–2134.PubMedCrossRefGoogle Scholar
  17. Gudi, S.R., Lee, A.A., Clark, C.B., Frangos, J.A., 1998, Equibiaxial strain and strain rate stimulate early activation of G proteins in cardiac fibroblasts. Am. J. Physiol. 274: C1424–1428.PubMedGoogle Scholar
  18. Katwa, L.C., Guarda, E., Weber, K.T., 1993, Endothelin receptors in cultured adult rat cardiac fibroblasts. Cardiovasc. Res. 27: 2125–2129.PubMedCrossRefGoogle Scholar
  19. Kouchi, I., Zolk, O., Jockenhövel, F., Itter, G., Linz, W., Cremers, B., Böhm, M., 2000, Increase in Giα-protein accompanies progression of post-infarction remodeling in hypertensive cardiomyopathy. Hypertension. 36: 42–47.PubMedCrossRefGoogle Scholar
  20. Lopez, B., Querejeta, R., Varo, N., Gonzalez, A., Larman, M., Martinez Ubago, J.L., Diez, J., 2001, Usefulness of serum carboxy-terminal propeptide of procollagen type I in assessment of the cardioreparative ability of antihypertensive treatment in hypertensive patients. Circulation. 104: 286–291.PubMedCrossRefGoogle Scholar
  21. Matsusaka, T., Katori, H., Inagami, T., Fogo, A., Ichikawa, I., 1999, Communication between myocytes and fibroblasts in cardiac remodeling in angiotensin chimeric mice. J. Clin. Invest. 103: 1451–1458.PubMedCentralPubMedCrossRefGoogle Scholar
  22. Montfort, I. and Perez-Tamayo, R., 1975, The distribution of collagenase in normal rat tissues. J. Histochem. Cytochem. 23: 910–920.PubMedCrossRefGoogle Scholar
  23. Mujumdar, V.S., Smiley, L.M., Tyagi, S.C., 2001, Activation of matrix metalloproteinase dilates and decreases cardiac tensile strength. Int. J. Cardiol. 79: 277–286.PubMedCrossRefGoogle Scholar
  24. Nagatomo, Y., Carabello, B.A., Coker, ML., McDermott, P.J., Nemoto, S., Hamawaki, M., Spinale, F.G., 2000, Differential effects of pressure or volume overload on myocardial MMP levels and inhibitory control. Am. J. Physiol. Heart. Circ. Physiol. 278: H151–161.PubMedGoogle Scholar
  25. Olivetti, G., Melissari, M., Balbi, T., Quaini, F., Cigola, E., Sonnenblick, E.H., Anversa, P., 1994, Myocyte cellular hypertrophy is responsible for ventricular remodelling in the hypertrophied heart of middle aged individuals in the absence of cardiac failure. Cardiovasc. Res. 28: 1199–1208.PubMedCrossRefGoogle Scholar
  26. Pathak, M., Sarkar, S., Vellaichamy, E., Sen, S., 2001, Role of myocytes in myocardial collagen production. Hypertension. 37: 833–840.PubMedCrossRefGoogle Scholar
  27. Pearlman, E.S., Weber, K.T., Janicki, J.S., Pietra, G.G., Fishman, A.P., 1982, Muscle fiber orientation and connective tissue content in the hypertrophied human heart. Lab. Invest. 46: 158–164.PubMedGoogle Scholar
  28. Sanderson, N., Factor, V., Nagy, P., Kopp, J., Kondaiah, P., Wakefield, L., Roberts, A.B., Sporn, M.B., Thorgeirsson, S.S., 1995, Hepatic expression of mature transforming growth factor beta 1 in transgenic mice results in multiple tissue lesions. Proc. Natl. Acad. Sci. U.S.A. 92: 2572–2576.PubMedCentralPubMedCrossRefGoogle Scholar
  29. Schunkert, H., Orzechowski, H.D., Bocker, W., Meier, R., Riegger, G.A., Paul, M., 1999, The cardiac endothelin system in established pressure overload left ventricular hypertrophy. J. Mol. Med. 77: 623–630.PubMedCrossRefGoogle Scholar
  30. Seeland, U., Kouchi, I., Zolk, O., Itter, G., Linz, W., Böhm, M., 2002a, Effect of ramipril and furosemide treatment on interstitial remodeling in post-infarction heart failure rat hearts. J. Mol. Cell. Cardiol. 34: 151–163.PubMedCrossRefGoogle Scholar
  31. Seeland, U., Haeuseler, C., Hinrichs, R., Rosenkranz, S., Pfitzner, T., Scharffetter-Kochanek, K., Böhm, M., 2002b, Myocardial fibrosis in transforming growth factor-beta(l) (TGF-beta(l)) transgenic mice is associated with inhibition of interstitial collagenase. Eur. J. Clin. Invest. 32: 295–303.PubMedCrossRefGoogle Scholar
  32. Spinale, F.G., 2002, Bioactive peptide signaling within the myocardial interstitium and the matrix metalloproteinases. Circ. Res. 91: 1082–1084.PubMedCrossRefGoogle Scholar
  33. Tsuruda, T., Boerrigter, G., Huntley, B.K., Noser, J.A., Cataliotti, A., Costello-Boerrigter, L.C., Chen, H.H., Burnett, J.C. Jr., 2002, Brain natriuretic Peptide is produced in cardiac fibroblasts and induces matrix metalloproteinases. Circ. Res. 91: 1127–1134.PubMedCrossRefGoogle Scholar
  34. Villarreal, F.J. and Dillmann, W.H., 1992, Cardiac hypertrophy-induced changes in mRNA levels for TGF-beta 1, fibronectin and collagen. Am. J. Physiol. 262: H1861–H1866.PubMedGoogle Scholar
  35. Weber, K.T. and Brilla, C.G., 1991, Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system.Circulation. 83: 1849–1865.PubMedCrossRefGoogle Scholar
  36. Weber, K.T., Brilla, C.G., Campbell, S.E., 1992, Regulatory mechanisms of myocardial hypertrophy and fibrosis: results of in vivo studies. Cardiology. 81: 266–273.PubMedCrossRefGoogle Scholar
  37. Yamamoto, K., Masuyama, T., Sakata, Y., Mano, T., Nishikawa, N., Kondo, H., Akehi, N., Kuzuya, T., Miwa, T., Hori, M., 2000, Roles of renin-angiotensin and endothelin systems in development of diastolic heart failure in hypertensive hearts. Cardiovasc. Res. 47: 274–283.PubMedCrossRefGoogle Scholar
  38. Zolk, O., Quattek, J., Seeland, U., El-Armouche, A., Eschenhagen, T., Böhm, M., 1999, Expression of endothelin-1, endothelin-converting enzyme, and endothelin receptors in chronic heart failure. Circulation. 99: 2118–2123.PubMedCrossRefGoogle Scholar
  39. Zolk, O., Quattek, J., Seeland, U., El-Armouche, A., Eschenhagen, T., Böhm, M., 2002, Activation of the cardiac endothelin system in left ventricular hypertrophy before onset of heart failure in TG(mREN2)27 rats. Cardiovasc. Res. 53: 363–371.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2003

Authors and Affiliations

  • Ute Seeland
    • 1
  • Michael Böhm
    • 1
  1. 1.Internal Medicine III (Cardiology and Angiology)The Saarland University HospitalHomburgGermany

Personalised recommendations